Genetic modifiers modulate phenotypic expression of tafazzin deficiency in a mouse model of Barth syndrome

Suya Wang,Erika Yazawa,Neil Mazumdar,Alexander Hauschild,Qing Ma,Haiyan Wu,Yang Xu,Xu Shi,Douglas Strathdee,Robert E Gerszten,Michael Schlame,William T Pu,Erin Keating

DOI: https://doi.org/10.1093/hmg/ddad041

IF: 5.1214

2023-03-16

Human Molecular Genetics

Abstract:Barth syndrome is an X-linked disorder caused by loss-of-function mutations in Tafazzin ( TAZ ), an acyltransferase that catalyzes remodeling of cardiolipin, a signature phospholipid of the inner mitochondrial membrane. Patients develop cardiac and skeletal muscle weakness, growth delay, and neutropenia, although phenotypic expression varies considerably between patients. Taz knockout mice recapitulate many of the hallmark features of the disease. We used mouse genetics to test the hypothesis that genetic modifiers alter the phenotypic manifestations of Taz inactivation. We crossed Taz KO/X females in the C57BL6/J inbred strain to males from 8 inbred strains and evaluated the phenotypes of first generation (F1) Taz KO/Y progeny, compared to Taz WT/Y littermates. We observed that genetic background strongly impacted phenotypic expression. C57BL6/J and CAST/EiJ[F1] Taz KO/Y mice developed severe cardiomyopathy, whereas A/J[F1] Taz KO/Y mice had normal heart function. C57BL6/J and WSB/EiJ[F1] Taz KO/Y mice had severely reduced treadmill endurance, whereas endurance was normal in A/J[F1] and CAST/EiJ[F1] Taz KO/Y mice. In all genetic backgrounds, cardiolipin showed similar abnormalities in knockout mice, and transcriptomic and metabolomic investigations identified signatures of mitochondrial uncoupling and activation of the integrated stress response. Taz KO/Y cardiac mitochondria were small, clustered, and had reduced cristae density in knockouts in severely affected genetic backgrounds but were relatively preserved in the permissive A/J[F1] strain. Gene expression and mitophagy measurements were consistent with reduced mitophagy in knockout mice in genetic backgrounds intolerant of Taz mutation. Our data demonstrate that genetic modifiers powerfully modulate phenotypic expression of Taz loss-of-function and act downstream of cardiolipin, possibly by altering mitochondrial quality control.

genetics & heredity,biochemistry & molecular biology